MTMari Takahashi

Mari Takahashi

*This is an algorithmically generated author record based on publicly available information.

Mari Takahashi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pathogenicity of the novel antigenic variant infectious bursal disease virus B2977CE2C3 isolated in Japan: Histological analysis of experimentally infected chickens

    by Soma Ito, Mari Takahashi, Kazumoto Shibuya, Atsushi Kato, Nobuyuki Tsutsumi, Katsuaki Sugiura

    Infectious bursal disease (IBD) is an immunosuppressive disease caused by the IBD virus (IBDV), leading to substantial economic losses in the poultry industry. Recently, a novel antigenic variant IBDV (nvIBDV) has emerged in China and spread across Asia, including Japan. We previously isolated and characterized the nvIBDV strain, B2977CE2C3, by experimentally infecting specific pathogen-free chickens. Herein, we performed histological examinations of systemic organs using tissue samples from the infected chickens. At 3 days post-inoculation (dpi), lymphocyte depletion was observed in the bursa of Fabricius (BF), cecal tonsil, spleen, and thymic cortex. During the acute phase, the BF exhibited marked inflammation and accumulation of cell debris, likely apoptotic remnants. Immunohistochemistry and quantitative image analysis revealed significant B cell depletion in the BF and spleen, persisting for up to 21 dpi. In addition, structural destruction of the BF, including loss of follicles, epithelial infoldings, replacement by epithelial reticular cells, and stromal fibrosis, was observed. IBDV antigens were immunohistochemically detected in the BF and cecal tonsil during early infection. The bone marrow contained lymphoid cell aggregations, suggesting increased lymphopoiesis. These findings indicate that the pathogenicity of nvIBDV is comparable with that of classical IBDV (genogroup A1), although it belongs to genogroup A2. Notably, nvIBDV can induce chronic immunosuppression due to prolonged B cell depletion in the BF and spleen, thereby increasing the susceptibility to secondary infections and interfering with subsequent vaccinations. This study highlights the pathogenic potential of nvIBDV and provides valuable pathological insights for understanding its pathogenesis and evaluating preventive strategies.

  • Open Access

    Sporadic Outbreaks of Avian Infectious Bronchitis Viruses Highly Similar to the S95 Live Attenuated Vaccine Strain in Japan: A Comparative Study of Ten Field Isolates and S95

    by Ryohei Nukui, Mari Takahashi, Atsushi Kato, Shiori Oguro, Erika Tanahashi, Takashi Ohmori, Nobuyuki Tsutsumi

    Background: As infectious bronchitis virus (IBV) strains similar to the IBV S95 live attenuated vaccine strain have been occasionally detected in poultry farms in Japan, we investigated the suspicion that outbreaks of the disease were related to the S95 vaccine. Methods: We isolated ten S95 vaccine-like strains, classified in the JP-I genotype of S1, the VIb (Y-4) genogroup of S2, and the GI-18 lineage, from IBV-affected chickens in Japan between 2020 and 2024. The whole-genome sequence and adaptation to embryonated chicken eggs were investigated. We developed a method for distinguishing the S95 vaccine strain from S95-like wild-type strains using specific primer sets having either the S95 vaccine or S95 parent-specific nucleotide at the 3′ termini of primers on the ORF2 gene. Results: Nine of ten S95 vaccine-like strains lacked identical mutations to the ORF1ab, ORF2, and ORF5a genes that the S95 vaccine strain acquired during attenuation. The remaining S95-like strain, B3389, had identical mutations to the S95 vaccine strain in the ORF1ab and ORF5a genes. The B3389 strain, however, had strain-specific nucleotides that were not found in the S95 vaccine or S95 parent strains, and produced fewer embryonated egg-adapted phenotypes than the S95 vaccine strain. Conclusions: The ten S95-like strains appear not to have emerged from the S95 vaccine strain. Instead, sporadic outbreaks of S95 vaccine-like IBV strains in Japan were indicated. A method for distinguishing and excluding the S95-like wild-type strains as suspected revertants of the S95 vaccine may be utilized for comprehensive IBV surveillance to facilitate development of a vaccination strategy.

  • Open Access

    Novel Antigenic Variant Infectious Bursal Disease Virus Outbreaks in Japan from 2014 to 2023 and Characterization of an Isolate from Chicken

    by Mari Takahashi, Shiori Oguro, Atsushi Kato, Soma Ito, Nobuyuki Tsutsumi

    Novel antigenic variant strains of the infectious bursal disease virus (IBDV) classified into genogroup A2d have been found in the western part of Japan since 2017. Novel antigenic variant IBDVs now occur in higher frequencies in poultry houses and have been detected in the eastern part of Japan, indicating the spread of IBDVs despite the usual IBDV vaccination. We isolated a novel antigenic variant IBDV, designated as the B2977CE2C3 strain. The B2977CE2C3 strain had two genogroup A2d specific amino acids—lysine and isoleucine, at 221 and 252 aa—along with the other genogroup A2 common amino acids in the projection domains of the VP2 protein corresponding to the virus-neutralizing epitopes and viral pathogenicity. Experimental infection of the B2977CE2C3 strain did not produce any apparent clinical signs in the specific-pathogen-free chickens during the observation period (21 days), but atrophy of the bursa of Fabricius (BF) was apparent. The mean BF to the body weight ratio was 0.35 in negative control chickens at 21 days post-infection (pi) but 0.06 in the B2977CE2C3 infected group. An extremely high copy number of the IBDV genome (>108 copies/µL) was observed in the BF at 3 days pi, while a high copy number of the IBDV genome (>106 copies/µL) was observed in the thymus, spleen cecal tonsil, and bone marrow even though macroscopic lesions were not apparent in these organs.